What if your daily scroll taking more than your time?
AstraZeneca has halted a Phase III trial of an experimental lung cancer treatment after an independent review found it was unlikely to deliver the benefits researchers had hoped for. The eVOLVE-Lung02 trial was studying volrustomig, the experimental drug in question, combined with chemotherapy as a first-line treatment for patients with…
Postdoctoral fellow Gina Wang at Harvard’s Wyss Institute is helping to develop a first-of-its-kind device that could one day transform how amyotrophic lateral sclerosis (ALS) is monitored and potentially diagnosed. As part of the NERVE Validation Project, Wang is working on ultra-sensitive technology to detect abnormal RNA molecules inside extracellular…